Favipiravir
CAT:
804-HY-14768-04
Size:
50 mg
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No
Favipiravir
- CAS Number: 259793-96-9
- UNSPSC Description: Favipiravir (T-705) is a potent viral RNA polymerase inhibitor, it is phosphoribosylated by cellular enzymes to its active form, Favipiravir-ribofuranosyl-5′-triphosphate (RTP). Favipiravir-RTP inhibits the influenza viral RNA-dependent RNA polymerase (RdRP) activity with an IC50 of 341 nM.
- Target Antigen: Bacterial; DNA/RNA Synthesis; Influenza Virus; SARS-CoV
- Type: Reference compound
- Related Pathways: Anti-infection;Cell Cycle/DNA Damage
- Applications: COVID-19-anti-virus
- Field of Research: Infection
- Assay Protocol: https://www.medchemexpress.com/T_705.html
- Solubility: DMSO : 100 mg/mL (ultrasonic)|H2O : 6.25 mg/mL (ultrasonic)
- Smiles: O=C(N)C1=NC(F)=CNC1=O
- Molecular Weight: 157.10
- References & Citations: [1]Furuta Y, et al. Favipiravir (T-705), a novel viral RNA polymerase inhibitor. Antiviral Res. 2013 Nov;100(2):446-54.|[2]Rocha-Pereira J, et al. Favipiravir (T-705) inhibits in vitro norovirus replication.
 Biochem Biophys Res Commun. 2012 Aug 10;424(4):777-80.
- Shipping Conditions: Room Temperature
- Clinical Information: Launched